...
首页> 外文期刊>Journal of Medicinal Chemistry >Novel Electrophilic and Photoaffinity Covalent Probes for Mapping the Cannabinoid 1 Receptor Allosteric Site(s)
【24h】

Novel Electrophilic and Photoaffinity Covalent Probes for Mapping the Cannabinoid 1 Receptor Allosteric Site(s)

机译:新型亲电和光亲和共价探针,用于映射大麻素1受体的变构位点

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Undesirable side effects associated with orthosteric agonists/antagonists of cannabinoid 1 receptor (CB1R), a tractable target for treating several pathologies affecting humans, have greatly limited their translational potential. Recent discovery of CB1R negative allosteric modulators (NAMs) has renewed interest in CB1R by offering a potentially safer therapeutic avenue. To elucidate the CB1R allosteric binding motif and thereby facilitate rational drug discovery, we report the synthesis and biochemical characterization of first covalent ligands designed to bind irreversibly to the CB1R allosteric site. Either an electrophilic or a photoactivatable group was introduced at key positions of two classical CB1R NAMs: Org27569 (1) and PSNCBAM-1 (2). Among these, 20 (GAT100) emerged as the most potent NAM in functional assays, did not exhibit inverse agonism, and behaved as a robust positive allosteric modulator of binding of orthosteric agonist CP55,940. This novel covalent probe can serve as a useful tool for characterizing CB1R allosteric ligand-binding motifs.
机译:与大麻素1受体(CB1R)的正构激动剂/拮抗剂相关的不良副作用(一种可治疗多种影响人类的病理学的靶标)极大地限制了其翻译潜力。 CB1R负变构调节剂(NAMs)的最新发现通过提供一种可能更安全的治疗途径而重新引起了人们对CB1R的兴趣。为了阐明CB1R变构结合基序,从而促进合理的药物发现,我们报道了设计成不可逆地结合到CB1R变构位点的第一个共价配体的合成和生化特性。在两个经典CB1R NAM的关键位置引入一个亲电子基团或一个可光活化基团:Org27569(1)和PSNCBAM-1(2)。其中,20(GAT100)在功能测定中显示为最有力的NAM,不表现出反向激动作用,并表现为结合正构激动剂CP55,940的强大正变构调节剂。这种新颖的共价探针可以用作表征CB1R变构配体结合基序的有用工具。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号